These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 38890507)

  • 1. Association of mitochondrial phosphoenolpyruvate carboxykinase with prognosis and immune regulation in hepatocellular carcinoma.
    Li C; Zhang ED; Ye Y; Xiao Z; Huang H; Zeng Z
    Sci Rep; 2024 Jun; 14(1):14051. PubMed ID: 38890507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dysregulation of phosphoenolpyruvate carboxykinase in cancers: A comprehensive analysis.
    Xue S; Cai Y; Liu J; Ji K; Yi P; Long H; Zhang X; Li P; Song Y
    Cell Signal; 2024 Aug; 120():111198. PubMed ID: 38697449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclin-Dependent Kinase 4 is expected to be a therapeutic target for hepatocellular carcinoma metastasis using integrated bioinformatic analysis.
    Zhang JN; Wei F; Lei LH; Yang Y; Yang Y; Zhou WP
    Bioengineered; 2021 Dec; 12(2):11728-11739. PubMed ID: 34784846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of NDRG1 leads to poor prognosis in hepatocellular carcinoma through mediating immune infiltration and EMT.
    Wang X; Sun R; Che N; Zhang D; Li Y; Zhao N
    Dig Liver Dis; 2024 Aug; 56(8):1382-1399. PubMed ID: 38290958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA H19 promotes the development of hepatitis B related hepatocellular carcinoma through regulating microRNA-22 via EMT pathway.
    Li L; Han T; Liu K; Lei CG; Wang ZC; Shi GJ
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5392-5401. PubMed ID: 31298392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intergrated analysis of ELMO1, serves as a link between tumour mutation burden and epithelial-mesenchymal transition in hepatocellular carcinoma.
    Peng H; Zhang Y; Zhou Z; Guo Y; Huang X; Westover KD; Zhang Z; Chen B; Hua Y; Li S; Xu R; Lin N; Peng B; Shen S
    EBioMedicine; 2019 Aug; 46():105-118. PubMed ID: 31324602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TRIM66 promotes malignant progression of hepatocellular carcinoma by inhibiting E-cadherin expression through the EMT pathway.
    Zhang HG; Pan YW; Feng J; Zeng CT; Zhao XQ; Liang B; Zhang WW
    Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):2003-2012. PubMed ID: 30915743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-370 Regulates Cellepithelial-Mesenchymal Transition, Migration, Invasion, and Prognosis of Hepatocellular Carcinoma by Targeting GUCD1.
    He Y; He X
    Yonsei Med J; 2019 Mar; 60(3):267-276. PubMed ID: 30799589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-451: epithelial-mesenchymal transition inhibitor and prognostic biomarker of hepatocelluar carcinoma.
    Huang JY; Zhang K; Chen DQ; Chen J; Feng B; Song H; Chen Y; Zhu Z; Lu L; De W; Wang R; Chen LB
    Oncotarget; 2015 Jul; 6(21):18613-30. PubMed ID: 26164082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpressed GNAZ predicts poor outcome and promotes G0/G1 cell cycle progression in hepatocellular carcinoma.
    Tian F; Cai D
    Gene; 2022 Jan; 807():145964. PubMed ID: 34530087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Restoring the epigenetically silenced PCK2 suppresses renal cell carcinoma progression and increases sensitivity to sunitinib by promoting endoplasmic reticulum stress.
    Xiong Z; Yuan C; Shi J; Xiong W; Huang Y; Xiao W; Yang H; Chen K; Zhang X
    Theranostics; 2020; 10(25):11444-11461. PubMed ID: 33052225
    [No Abstract]   [Full Text] [Related]  

  • 12. Increased expression of SLC46A3 to oppose the progression of hepatocellular carcinoma and its effect on sorafenib therapy.
    Zhao Q; Zheng B; Meng S; Xu Y; Guo J; Chen LJ; Xiao J; Zhang W; Tan ZR; Tang J; Chen L; Chen Y
    Biomed Pharmacother; 2019 Jun; 114():108864. PubMed ID: 30981107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Knockdown of the Sonic Hedgehog (SHH) Gene Inhibits Proliferation of Hep3B and SMMC-7721 Hepatocellular Carcinoma Cells via the PI3K/Akt/PCK1 Signaling Pathway.
    Chen Y; Zhu W
    Med Sci Monit; 2019 Aug; 25():6023-6033. PubMed ID: 31406102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long noncoding RNA CPS1-IT1 suppresses the metastasis of hepatocellular carcinoma by regulating HIF-1α activity and inhibiting epithelial-mesenchymal transition.
    Wang TH; Yu CC; Lin YS; Chen TC; Yeh CT; Liang KH; Shieh TM; Chen CY; Hsueh C
    Oncotarget; 2016 Jul; 7(28):43588-43603. PubMed ID: 27248828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteomic Analysis of Hepatocellular Carcinoma Tissues With Encapsulation Shows Up-regulation of Leucine Aminopeptidase 3 and Phosphoenolpyruvate Carboxykinase 2.
    Kuhara K; Kitagawa T; Baron B; Tokuda K; Sakamoto K; Nagano H; Nakamura K; Kobayashi M; Nagayasu H; Kuramitsu Y
    Cancer Genomics Proteomics; 2021; 18(3):307-316. PubMed ID: 33893083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-122 inhibits epithelial-mesenchymal transition in hepatocellular carcinoma by targeting Snail1 and Snail2 and suppressing WNT/β-cadherin signaling pathway.
    Jin Y; Wang J; Han J; Luo D; Sun Z
    Exp Cell Res; 2017 Nov; 360(2):210-217. PubMed ID: 28890291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-3607, a biomarker of hepatocellular carcinoma invasion and aggressiveness: Its relationship with epithelial-mesenchymal transition process.
    Hu WY; Wei HY; Liu LY; Li KM; Wang RB; Xu XQ; Feng R
    IUBMB Life; 2020 Aug; 72(8):1686-1697. PubMed ID: 32311821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SLC25A19 is a novel prognostic biomarker related to immune invasion and ferroptosis in HCC.
    Liu S; Zhang P; Wu Y; Zhou H; Wu H; Jin Y; Wu D; Wu G
    Int Immunopharmacol; 2024 Jul; 136():112367. PubMed ID: 38823177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated SLC1A5 associated with poor prognosis and therapeutic resistance to transarterial chemoembolization in hepatocellular carcinoma.
    Zhang G; Xiao Y; Tan J; Liu H; Fan W; Li J
    J Transl Med; 2024 Jun; 22(1):543. PubMed ID: 38844930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CASC15 promotes epithelial to mesenchymal transition and facilitates malignancy of hepatocellular carcinoma cells by increasing TWIST1 gene expression via miR-33a-5p sponging.
    Li Y; Chen G; Yan Y; Fan Q
    Eur J Pharmacol; 2019 Oct; 860():172589. PubMed ID: 31401158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.